1The Ohio State University College of Medicine, Columbus, Ohio.
2The Ohio State University College of Liberal Arts and Sciences, Columbus, Ohio.
J Natl Compr Canc Netw. 2024 Feb;22(1):26-33. doi: 10.6004/jnccn.2023.7075.
BACKGROUND: Based on the NCCN Guidelines for Soft Tissue Sarcoma (STS), treatment of extremity STS (ESTS) includes radiation therapy (RT) and surgical resection for tumors that are high-grade and >5 cm. The aim of this study was to describe the association between neighborhood socioeconomic status (nSES), concordance with NCCN Guidelines recommendations, and outcomes in patients with ESTS. METHODS: Patients with ESTS diagnosed from 2006 through 2018 were identified in SEER registries. The analytic cohort was restricted to patients with high-grade tumors >5 cm without nodal or distant metastases who received limb-sparing surgery. Patient demographics and tumor characteristics associated with receipt of RT were analyzed using adjusted regression analyses. Kaplan-Meier curves and adjusted accelerated failure time models were used to examine disparities in cancer-specific survival. RESULTS: Of 2,249 patients, 29.0% (n=648) received neoadjuvant RT, 49.7% (n=1,111) received adjuvant or intraoperative RT, and 21.3% (n=476) did not receive RT. In adjusted analyses, lower nSES was associated with lower likelihood of receiving RT (odds ratio, 0.70 [95% CI, 0.57-0.87]; P<.001). Low nSES was associated with worse cancer-specific survival (hazard ratio, 1.19 [95% CI, 1.01-1.40]; P=.04). Race and ethnicity were not significant predictors of receipt of RT or cancer-specific survival in the fully adjusted models. CONCLUSIONS: Patients from lower nSES areas were less likely to receive NCCN Guideline-recommended RT for their ESTS and had worse cancer-specific survival. Efforts to better define and resolve disparities in the treatment and survival of patients with ESTS are warranted.
背景:基于 NCCN 软组织肉瘤(STS)指南,肢体软组织肉瘤(ESTS)的治疗包括对高级别和>5cm 的肿瘤进行放射治疗(RT)和手术切除。本研究的目的是描述 ESTS 患者的邻里社会经济地位(nSES)、与 NCCN 指南建议的一致性与预后之间的关联。
方法:从 SEER 登记处中确定了 2006 年至 2018 年诊断为 ESTS 的患者。分析队列仅限于接受保肢手术的高级别>5cm 且无淋巴结或远处转移的患者。使用调整后的回归分析,分析了与接受 RT 相关的患者人口统计学和肿瘤特征。使用 Kaplan-Meier 曲线和调整后的加速失败时间模型来研究癌症特异性生存方面的差异。
结果:在 2249 名患者中,29.0%(n=648)接受了新辅助 RT,49.7%(n=1111)接受了辅助或术中 RT,21.3%(n=476)未接受 RT。在调整后的分析中,较低的 nSES 与接受 RT 的可能性较低相关(比值比,0.70[95%CI,0.57-0.87];P<.001)。低 nSES 与癌症特异性生存较差相关(风险比,1.19[95%CI,1.01-1.40];P=.04)。在完全调整的模型中,种族和民族不是接受 RT 或癌症特异性生存的显著预测因素。
结论:来自低 nSES 地区的患者接受 ESTS 治疗的 NCCN 指南推荐的 RT 可能性较低,癌症特异性生存较差。有必要努力更好地定义和解决 ESTS 患者治疗和生存方面的差异。
J Natl Compr Canc Netw. 2024-2
Cancers (Basel). 2024-12-7